. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Expert Rev Anticancer Ther. 2020 Jun 23;20(7):575–580. doi: 10.1080/14737140.2020.1781620

Table 1:

Summary of study comparing stenting and gastrojejunostomy for management of malignant gastric outlet obstruction

Year Authors	Treatment	n	Clinical success		Days to eat	Hospital Stay (days)	Re-intervention	Survival (median)
2007 Jeurnink et al [14]	Bypass	42	at least soft solid intake	59%	10 (mean)	18(mean)	6.4%	88 days
2007 Jeurnink et al [14]	Stent	53	at least soft solid intake	73%	3.6 (mean)	6 (mean)	13.9%	70 days
2010 Jeurnink et al [15]	Bypass	18	days with GOOSS > 2	72 (median)	8 (median)	15	11.1%	78 days
2010 Jeurnink et al [15]	Stent	21	days with GOOSS > 2	50 (median)	5 (median)	7	33.3%	56 days
2012 Chandrasegaram et al [16]	Bypass	19	Solid diet on day 10	37%	9 (median)	25	N/A	134 days
2012 Chandrasegaram et al [16]	Stent	26	Solid diet on day 10	73%	2 (median)	11	11.5%	70 days
2012 Roy [17]	Bypass	75	Relief of obstruction	100%	10.7 (mean)	10.7 (mean)	6.7%	132 days
2012 Roy [17]	Stent	29	Relief of obstruction	100%	1.5 (mean)	1.5 (mean)	13.8%	118 days
2013 Khashab [18]	Bypass	270	Oral intake at discharge	91%	N/A	13	8.7%	N/A
2013 Khashab [18]	Stent	120	Oral intake at discharge	87%	N/A	10.1	27.3%	N/A
2013 No et al [19]	Bypass	41	improvement of symptoms	95.1%	5 (median)	18	5.5%	293 days
2013 No et al [19]	Stent	72	improvement of symptoms	87.5%	2 (median)	16	43.0%	189 days